Publications by authors named "Tomas Uher"

Claim this Profile
R
Relationships of language features from spontaneous speech to objective and subjective cognition in people with multiple sclerosis.
Leila Simani, Martin Subert, Tomas Uher, Jan Rusz, Lauren Heuer

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From sunlight to MS fight: impact of vitamin D levels on multiple sclerosis activity.
Marta Vachova, Dominika Stastna, Aneta Mazouchova, Pavla Hruskova, Tomas Uher

Neurol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum bilirubin concentrations and their association with clinical and radiological outcomes in multiple sclerosis: A large cohort study.
Tomáš Uher, Pavlína Kleinová, Jana Woronyczová, Lubomír Štěpánek, Manuela Vaněčková

Ann Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Is Linked to Brain Volume Loss in Multiple Sclerosis.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner

Ann Clin Transl Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of brain volume on coronavirus disease of 2019 severity and subsequent cognitive decline in patients with multiple sclerosis.
Jens Devogelaere, Ann Van Remoortel, Delphine Van Laethem, Laetitia Della Faille, Marie B D'hooghe, Tomas Uher

J Neurol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminopeptidase N: a multifunctional and promising target in medicinal chemistry.
Oldřich Farsa, Tomáš Uher

RSC Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical risk stratification: Prague validation of the DAAE score, a clinical tool for estimating risk of disesase progression in multiple sclerosis.
Julia R Jelgerhuis, Tomas Uher, Eva Kubala Havrdova, Dana Horakova, Menno M Schoonheim

Mult Scler Relat Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of individual physiotherapy and telerehabilitation on back pain and quality of life in people with multiple sclerosis with mild and moderate disability.
Veronika Knapova, Barbora Grosserova, Renata Vetrovska, Tomas Uher, Klara Novotna

Mult Scler Relat Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study.
Balazs Lorincz, Michal Vrablik, Ramanathan Murali, Eva Kubala Havrdova, Dana Horakova, Tomas Uher

Acta Neurol Belg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid measures are associated with cognitive functioning in multiple sclerosis patients.
Balázs Lőrincz, Jiří Motýl, Lucie Friedová, Daniel Hrych, Eva Kubala Havrdová, Tomáš Uher

Mult Scler Relat Disord· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap.
Giuseppe Pontillo, Ferran Prados, Jordan Colman, Baris Kanber, Omar Abdel-Mannan, Tomas Uher

Neurology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis.
Veronica Ravano, Michaela Andelova, Gian Franco Piredda, Stefan Sommer, Samuele Caneschi, Tomas Uher

J Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis.
Tom A Fuchs, Robert Zivadinov, Tetyana Pryshchepova, Bianca Weinstock-Guttman, Michael G Dwyer, Tomas Uher

Mult Scler Relat Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis.
Jiri Motyl, Lucie Friedova, Ranjani Ganapathy Subramanian, Manuela Vaneckova, Tom A Fuchs, Tomas Uher

Acta Neurol Belg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis.
Veronica Ravano, Gian Franco Piredda, Jan Krasensky, Michaela Andelova, Tomas Uher

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interest in Telerehabilitation Among Patients with Mild to Severe Multiple Sclerosis: Results of the Czech Republic.
Klara Novotna, Jitka Zeiselova, Barbora Stanickova, Martina Kovari, Tomas Uher

Telemed J E Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?
Petra Rekova, Ivana Kovarova, Tomas Uher, Barbora Srpova, Gabriela Dostalova

Neurol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Vinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, Alex Rovira, Jaume Sastre-Garriga, Tomas Uher

Brain· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.
Tomas Uher, Adrian Adzima, Barbora Srpova, Libuse Noskova, Bénédicte Maréchal

Mult Scler· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS).
Klára Novotná, Jiří Motýl, Lucie Friedová, Ingrid Menkyová, Michaela Andělová, Tomáš Uher

Dysphagia· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS.
Andrea Burgetova, Petr Dusek, Tomas Uher, Manuela Vaneckova, Martin Vejrazka

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis.
Martin Šubert, Michal Novotný, Tereza Tykalová, Barbora Srpová, Lucie Friedová, Tomáš Uher

Ther Adv Neurol Disord· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection'[Multiple sclerosis and related disorders vol. 65 (2022) 104014].
Dominika Stastna, Ingrid Menkyova, Jiri Drahota, Tereza Hrnciarova, Eva Kubala Havrdova, Tomas Uher

Mult Scler Relat Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of bleeding after ground-level falls in elderly patients with atrial fibrillation and warfarin therapy.
Branislav Bezak, Marianna Barbierik Vachalcova, Viera Kissova, Peter Michalek, Jan Stevlik, Tomas Uher

Bratisl Lek Listy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years.
Devon Oship, Dejan Jakimovski, Niels Bergsland, Dana Horakova, Tomas Uher

Mult Scler Relat Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis